In our previous work, we have demonstrated that angiotensin II (AngII) and transforming growth factor β1 (TGF-β1), natural biomolecules found in various human tissues, are able to induce genetic, metabolic, and epigenetic alterations in AF-MSCs leading to the initiation of cardiomyogenic differentiation [9]. This evidence concerns the gene AGT and atrial fibrillation.